Abeta deposition and related pathology in an APP x PS1 transgenic mouse model of Alzheimer's disease.

Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice

Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., Yang, F., & Cole, G. (1996) · Science · doi:10.1126/science.274.5284.99 · Cited by 4,210 · see citing works

Triple-Transgenic Model of Alzheimer’s Disease with Plaques and Tangles

Oddo, S., Caccamo, A., Shepherd, J. D., Murphy, M. P., Golde, T. E., Kayed, R., Metherate, R., Mattson, M. P., Akbari, Y., & LaFerla, F. M. (2003) · Neuron · doi:10.1016/s0896-6273(03)00434-3 · Cited by 4,126 · see citing works

Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein

Games, D., Adams, D., Alessandrini, R., Barbour, R., Borthelette, P., Blackwell, C., Carr, T., Clemens, J., Donaldson, T., Gillespie, F., et al. (1995) · Nature · doi:10.1038/373523a0 · Cited by 2,516 · see citing works

Synapse loss in frontal cortex biopsies in Alzheimer's disease: Correlation with cognitive severity

DeKosky, S. T., & Scheff, S. W. (1990) · Annals of Neurology · doi:10.1002/ana.410270502 · Cited by 2,376 · see citing works

Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology

Sturchler-Pierrat, C., Abramowski, D., Duke, M., Wiederhold, K.-H., Mistl, C., Rothacher, S., Ledermann, B., Bürki, K., Frey, P., Paganetti, P. A., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.24.13287 · Cited by 1,507 · see citing works

Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes

Holcomb, L., Gordon, M. N., McGowan, E., Yu, X., Benkovic, S., Jantzen, P., Wright, K., Saad, I., Mueller, R., Morgan, D., et al. (1998) · Nature Medicine · doi:10.1038/nm0198-097 · Cited by 1,386 · see citing works

Age-Dependent Changes in Brain, CSF, and Plasma Amyloid β Protein in the Tg2576 Transgenic Mouse Model of Alzheimer's Disease

Kawarabayashi, T., Younkin, L. H., Saido, T. C., Shoji, M., Ashe, K. H., & Younkin, S. G. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-02-00372.2001 · Cited by 1,053 · see citing works

Accelerated Amyloid Deposition in the Brains of Transgenic Mice Coexpressing Mutant Presenilin 1 and Amyloid Precursor Proteins

Borchelt, D. R., Ratovitski, T., van Lare, J., Lee, M. K., Gonzales, V., Jenkins, N. A., Copeland, N. G., Price, D. L., & Sisodia, S. S. (1997) · Neuron · doi:10.1016/s0896-6273(00)80974-5 · Cited by 1,023 · see citing works

Early-onset Amyloid Deposition and Cognitive Deficits in Transgenic Mice Expressing a Double Mutant Form of Amyloid Precursor Protein 695

Chishti, M. A., Yang, D.-S., Janus, C., Phinney, A. L., Horne, P., Pearson, J., Strome, R., Zuker, N., Loukides, J., French, J., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100710200 · Cited by 955 · see citing works

Ibuprofen Suppresses Plaque Pathology and Inflammation in a Mouse Model for Alzheimer's Disease

Lim, G. P., Yang, F., Chu, T., Chen, P., Beech, W. K., Teter, B., Tran, T., Ubeda, O. J., Ashe, K. H., Frautschy, S. A., et al. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-15-05709.2000 · Cited by 876 · see citing works

Microglial response to amyloid plaques in APPsw transgenic mice.

Frautschy, S. A., Yang, F., Irrizarry, M., Hyman, B. T., Saido, T. C., Hsiao, K., & Cole, G. M. (1998) · Europe PMC (PubMed Central) · Cited by 592 · see citing works

Anti-Inflammatory Drug Therapy Alters β-Amyloid Processing and Deposition in an Animal Model of Alzheimer's Disease

Yan, Q., Zhang, J., Liu, H., Babu-Khan, S., Vassar, R., Biere, A. L., Citron, M., & Landreth, G. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-20-07504.2003 · Cited by 469 · see citing works

Nonsteroidal Anti-Inflammatory Drugs for the Prevention of Alzheimer’s Disease: A Systematic Review

Szekely, C. A., Thorne, J. E., Zandi, P. P., Ek, M., Messias, E., Breitner, J. C. S., & Goodman, S. N. (2004) · Neuroepidemiology · doi:10.1159/000078501 · Cited by 394 · see citing works

The Endosomal-Lysosomal System of Neurons in Alzheimer's Disease Pathogenesis: A Review

Nixon, R. A., Cataldo, A. M., & Mathews, P. M. (2000) · Neurochemical Research · doi:10.1023/a:1007675508413 · Cited by 315 · see citing works

Hippocampal Neuron Loss Exceeds Amyloid Plaque Load in a Transgenic Mouse Model of Alzheimer's Disease

Schmitz, C., Rutten, B. P. F., Pielen, A., Schäfer, S., Wirths, O., Tremp, G., Czech, C., Blanchard, V., Multhaup, G., Rezaie, P., et al. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63235-x · Cited by 281 · see citing works

Amyloid-Associated Neuron Loss and Gliogenesis in the Neocortex of Amyloid Precursor Protein Transgenic Mice

Bondolfi, L., Calhoun, M., Ermini, F., Kuhn, H. G., Wiederhold, K.-H., Walker, L., Staufenbiel, M., & Jucker, M. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-02-00515.2002 · Cited by 213 · see citing works

Cognitive correlates of Aβ deposition in male and female mice bearing amyloid precursor protein and presenilin-1 mutant transgenes

Howlett, D. R., Richardson, J. C., Austin, A., Parsons, A. A., Bate, S. T., Davies, D. C., & Gonzalez, M. I. (2004) · Brain Research · doi:10.1016/j.brainres.2004.05.029 · Cited by 212 · see citing works

Dentate gyrus volume is reduced before onset of plaque formation in PDAPP mice: A magnetic resonance microscopy and stereologic analysis

Redwine, J. M., Kosofsky, B. E., Jacobs, R. E., Games, D., Reilly, J. F., Morrison, J. H., Young, W. G., & Bloom, F. E. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.242746599 · Cited by 201 · see citing works

Isolation, Chemical Characterization, and Quantitation of Aβ 3-Pyroglutamyl Peptide from Neuritic Plaques and Vascular Amyloid Deposits

Kuo, Y.-M., Emmerling, M. R., Woods, A. S., Cotter, R. J., & Roher, A. E. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.7083 · Cited by 178 · see citing works

Inflammatory cytokines in the brain: Does the CNS shape immune responses?

Owens, T., Renno, T., Taupin, V., & Krakowski, M. L. (1994) · Immunology Today · doi:10.1016/0167-5699(94)90218-6 · Cited by 174 · see citing works

Vulnerability of cortical neurons to Alzheimer's and Parkinson's diseases

Braak, H., Rüb, U., Schultz, C., & Tredici, K. D. (2006) · Journal of Alzheimer s Disease · doi:10.3233/jad-2006-9s305 · Cited by 163 · see citing works

Accelerated amyloid deposition, neurofibrillary degeneration and neuronal loss in double mutant APP/tau transgenic mice

Ribé, E. M., Pérez, M., Puig, B., Gich, I., Lim, F., Cuadrado, M., Sesma, T., Catena, S., Sánchez, B., Nieto, M., et al. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.05.027 · Cited by 162 · see citing works

Involvement of two different cell death pathways in retinal atrophy of cathepsin D-deficient mice

Koike, M., Shibata, M., Ohsawa, Y., Nakanishi, H., Koga, T., Kametaka, S., Waguri, S., Momoi, T., Kominami, E., Peters, C., et al. (2003) · Molecular and Cellular Neuroscience · doi:10.1016/s1044-7431(03)00035-6 · Cited by 153 · see citing works

Glia as a Therapeutic Target: Selective Suppression of Human Amyloid-β-Induced Upregulation of Brain Proinflammatory Cytokine Production Attenuates Neurodegeneration

Ranaivo, H. R., Craft, J. M., Hu, W., Guo, L., Wing, L. K., Eldik, L. J. V., & Watterson, D. M. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.4652-05.2006 · Cited by 137 · see citing works

Cognitive decline strongly correlates with cortical atrophy in Alzheimer’s dementia

Mouton, P. R., Martin, L. J., Calhoun, M. E., Forno, G. D., & Price, D. L. (1998) · Neurobiology of Aging · doi:10.1016/s0197-4580(98)00080-3 · Cited by 128 · see citing works

Aging Increased Amyloid Peptide and Caused Amyloid Plaques in Brain of Old APP/V717I Transgenic Mice by a Different Mechanism than Mutant Presenilin1

Dewachter, I., Dorpe, J. V., Smeijers, L., Gilis, M., Kuipéri, C., Laenen, I., Caluwaerts, N., Moechars, D., Checler, F., Vanderstichele, H., et al. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-17-06452.2000 · Cited by 104 · see citing works

Neurodegenerative Changes Associated with β-Amyloid Deposition in the Brains of Mice Carrying Mutant Amyloid Precursor Protein and Mutant Presenilin-1 Transgenes

Kurt, M. A., Davies, D. C., Kidd, M., Duff, K., Rolph, S. C., JENNINGS, K. H., & Howlett, D. R. (2001) · Experimental Neurology · doi:10.1006/exnr.2001.7717 · Cited by 88 · see citing works

Ultrastructural and behavioural changes precede amyloid deposition in a transgenic model of Alzheimer’s disease

Richardson, J. C., Kendal, C., Anderson, R., Priest, F., Gower, E., Soden, P. E., Gray, R., Topps, S., Howlett, D. R., Lavender, D., et al. (2003) · Neuroscience · doi:10.1016/s0306-4522(03)00389-0 · Cited by 85 · see citing works

The topographic distribution of brain atrophy in Alzheimer's disease

Mann, D. M. A. (1991) · Acta Neuropathologica · doi:10.1007/bf00294434 · Cited by 74 · see citing works

Novel Cathepsin D Inhibitors Block the Formation of Hyperphosphorylated Tau Fragments in Hippocampus

Bi, X., Haque, T. S., Zhou, J., Skillman, A. G., Lin, B., Lee, C. E., Kuntz, I. D., Ellman, J. A., & LYNCH, G. S. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0741469.x · Cited by 70 · see citing works

β-Amyloid Immunoreactivity in Astrocytes in Alzheimer's Disease Brain Biopsies: An Electron Microscope Study

Kurt, M. A., Davies, D. C., & Kidd, M. (1999) · Experimental Neurology · doi:10.1006/exnr.1999.7096 · Cited by 57 · see citing works

Toxicity of Pyroglutaminated Amyloid β‐Peptides 3(pE)‐40 and ‐42 Is Similar to That of Aβ1‐40 and ‐42

Tekirian, T. L., Yang, A., Glabe, C. G., & Geddes, J. W. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0731584.x · Cited by 53 · see citing works

Association of plasma clusterin concentration with severity, pathology, and progression in Alzheimer disease

Thambisetty, M., Simmons, A., Velayudhan, L., Hye, A., Campbell, J., Zhang, Y., Wahlund, L.-O., Westman, E., Kinsey, A., Güntert, A., et al. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.78 · Cited by 405 · see citing works

Intracerebral Transplantation of Bone Marrow-Derived Mesenchymal Stem Cells Reduces Amyloid-Beta Deposition and Rescues Memory Deficits in Alzheimer's Disease Mice by Modulation of Immune Responses

Lee, J. K., Jin, H. K., Endo, S., Schuchman, E. H., Carter, J., & Bae, J.-S. (2009) · Stem Cells · doi:10.1002/stem.277 · Cited by 303 · see citing works

A Genome-wide Gene-Expression Analysis and Database in Transgenic Mice during Development of Amyloid or Tau Pathology

Matarin, M., Salih, D. A., Yasvoina, M., Cummings, D. M., Guelfi, S., Liu, W., Nahaboo Solim, M. A., Moens, T. G., Paublete, R. M., Ali, S. S., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2014.12.041 · Cited by 290 · see citing works

Untangling the association of amyloid-β and tau with synaptic and axonal loss in Alzheimer’s disease

Pereira, J. B., Janelidze, S., Ossenkoppele, R., Kvartsberg, H., Brinkmalm, A., Mattsson, N., Stomrud, E., Smith, R. A., Zetterberg, H., Blennow, K., et al. (2020) · Brain · doi:10.1093/brain/awaa395 · Cited by 201 · see citing works

Soluble oligomeric amyloid-β induces calcium dyshomeostasis that precedes synapse loss in the living mouse brain

Arbel‐Ornath, M., Hudry, E., Boivin, J. R., Hashimoto, T., Takeda, S., Kuchibhotla, K. V., Hou, S. S., Lattarulo, C. R., Belcher, A. M., Shakerdge, N. B., et al. (2017) · Molecular Neurodegeneration · doi:10.1186/s13024-017-0169-9 · Cited by 168 · see citing works

Activation of mTOR: a culprit of Alzheimer’s disease?

Cai, Z., Zhou, Y., Xiao, M., Yan, L.-J., & He, W. (2015) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s75717 · Cited by 161 · see citing works

Intracerebral Injection of Extracellular Vesicles from Mesenchymal Stem Cells Exerts Reduced Aβ Plaque Burden in Early Stages of a Preclinical Model of Alzheimer’s Disease

Elia, C. A., Tamborini, M., Rasile, M., Desiato, G., Marchetti, S., Swuec, P., Mazzitelli, S., Clemente, F., Anselmo, A., Matteoli, M., et al. (2019) · Cells · doi:10.3390/cells8091059 · Cited by 142 · see citing works

A unifying hypothesis for Alzheimer's disease: from plaques to neurodegeneration

Edwards, F. A. (2019) · Trends in Neurosciences · doi:10.1016/j.tins.2019.03.003 · Cited by 140 · see citing works

Stabilizing ER Ca2+ Channel Function as an Early Preventative Strategy for Alzheimer’s Disease

Chakroborty, S., Briggs, C. A., Miller, M. B., Goussakov, I. V., Schneider, C., Kim, J. S., Wicks, J. M., Richardson, J. C., Conklin, V., Cameransi, B. G., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0052056 · Cited by 136 · see citing works

Hippocampal interneuron loss in an APP/PS1 double mutant mouse and in Alzheimer’s disease

Takahashi, H., Brasnjevic, I., Rutten, B. P. F., Van Der Kolk, N., Perl, D. P., Bouras, C., Steinbusch, H. W. M., Schmitz, C., Hof, P. R., & Dickstein, D. L. (2010) · Brain Structure and Function · doi:10.1007/s00429-010-0242-4 · Cited by 124 · see citing works

Non-invasive infra-red therapy (1072 nm) reduces β-amyloid protein levels in the brain of an Alzheimer’s disease mouse model, TASTPM

Grillo, S. L., Duggett, N. A., Ennaceur, A., & Chazot, P. L. (2013) · Journal of Photochemistry and Photobiology B Biology · doi:10.1016/j.jphotobiol.2013.02.015 · Cited by 113 · see citing works

Longitudinal regional brain volume changes quantified in normal aging and Alzheimer's APP×PS1 mice using MRI

Maheswaran, S., Barjat, H., Rueckert, D., Bate, S. T., Howlett, D. R., Tilling, L. C., Smart, S., Pohlmann, A., Richardson, J. C., Hartkens, T., et al. (2009) · Brain Research · doi:10.1016/j.brainres.2009.02.045 · Cited by 103 · see citing works

Inflammation in transgenic mouse models of neurodegenerative disorders

Schwab, C., Klegeris, A., & McGeer, P. L. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.10.013 · Cited by 97 · see citing works

Viscoelasticity of amyloid plaques in transgenic mouse brain studied by Brillouin microspectroscopy and correlative Raman analysis

Mattana, S., Caponi, S., Tamagnini, F., Fioretto, D., & Palombo, F. (2017) · Journal of Innovative Optical Health Sciences · doi:10.1142/s1793545817420019 · Cited by 92 · see citing works

The Protective Effects of Osteocyte‐Derived Extracellular Vesicles Against Alzheimer's Disease Diminished with Aging

Jiang, Y., Wang, Z., Liu, X., Wan, M., Liu, Y., Jiao, B., Liao, X., Luo, Z., Wang, Y., Hong, C., et al. (2022) · Advanced Science · doi:10.1002/advs.202105316 · Cited by 87 · see citing works

Preclinical Alzheimer disease: Brain oxidative stress, Aβ peptide and proteomics

Aluise, C. D., Sowell, R. A., Beckett, T. L., Murphy, M. P., Cai, J., Pierce, W. M. J., Markesbery, W. R., & Butterfield, D. A. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.04.011 · Cited by 83 · see citing works

The Transcriptional Landscape of Microglial Genes in Aging and Neurodegenerative Disease

Bonham, L. W., Sirkis, D. W., & Yokoyama, J. S. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01170 · Cited by 83 · see citing works

First effects of rising amyloid-β in transgenic mouse brain: synaptic transmission and gene expression

Cummings, D. M., Liu, W., Portelius, E., Bayram, S., Yasvoina, M. V., Ho, H., Smits, H., Ali, S. S., Steinberg, R., Pegasiou, C.-M., et al. (2015) · Brain · doi:10.1093/brain/awv127 · Cited by 81 · see citing works

Distinct disease‐sensitive GABAergic neurons in the perirhinal cortex of Alzheimer's mice and patients

Sánchez‐Mejías, E., Nuñez‐Diaz, C., Sanchez-Varo, R. M., Gómez-Arboledas, Á., García‐León, J. A., Fernandez-Valenzuela, J. J., Mejias‐Ortega, M., Trujillo‐Estrada, L., Baglietto‐Vargas, D., Moreno‐González, I., et al. (2019) · Brain Pathology · doi:10.1111/bpa.12785 · Cited by 77 · see citing works

Activation of PARP by Oxidative Stress Induced by β-Amyloid: Implications for Alzheimer’s Disease

Abeti, R., & Duchen, M. R. (2012) · Neurochemical Research · doi:10.1007/s11064-012-0895-x · Cited by 78 · see citing works

APP transgenic mice: their use and limitations

Balducci, C., & Forloni, G. (2011) · NeuroMolecular Medicine · doi:10.1007/s12017-010-8141-7 · Cited by 79 · see citing works

Central Nervous System Penetration for Small Molecule Therapeutic Agents Does Not Increase in Multiple Sclerosis- and Alzheimer’s Disease-Related Animal Models Despite Reported Blood-Brain Barrier Disruption

Cheng, Z., Zhang, J., Liu, H., Li, Y., Zhao, Y., & Yang, E. (2010) · Drug Metabolism and Disposition · doi:10.1124/dmd.110.033324 · Cited by 68 · see citing works

PET Imaging of Copper Trafficking in a Mouse Model of Alzheimer Disease

Torres, J. B., Andreozzi, E. M., Dunn, J., Siddique, M., Szanda, I., Howlett, D. R., Sunassee, K., & Blower, P. J. (2015) · Journal of Nuclear Medicine · doi:10.2967/jnumed.115.162370 · Cited by 67 · see citing works

Modeling Alzheimer’s disease: from past to future

Saraceno, C., Musardo, S., Marcello, E. E., Pelucchi, S., & Luca, M. D. (2013) · Frontiers in Pharmacology · doi:10.3389/fphar.2013.00077 · Cited by 61 · see citing works

Early-Onset and Robust Amyloid Pathology in a New Homozygous Mouse Model of Alzheimer's Disease

Willuweit, A., Velden, J., Godemann, R., Manook, A., Jetzek, F., Tintrup, H., Kauselmann, G., Zevnik, B., Henriksen, G., Drzezga, A., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007931 · Cited by 60 · see citing works

Metabonomic Profiling of TASTPM Transgenic Alzheimer’s Disease Mouse Model

Hu, Z., Browne, E. R., Liu, T., Angel, T. E., Ho, P. C., & Chan, E. C. Y. (2012) · Journal of Proteome Research · doi:10.1021/pr300666p · Cited by 58 · see citing works

Characterization of histamine H3 receptors in Alzheimer's Disease brain and amyloid over‐expressing TASTPM mice

Medhurst, A. D., Roberts, J., Lee, J., Chen, C., Brown, S., Roman, S. A., & Lai, M. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2008.00075.x · Cited by 57 · see citing works

18F-FDG-PET in Mouse Models of Alzheimer's Disease

Bouter, C., & Bouter, Y. (2019) · Frontiers in Medicine · doi:10.3389/fmed.2019.00071 · Cited by 51 · see citing works

DHA Ameliorates Cognitive Ability, Reduces Amyloid Deposition, and Nerve Fiber Production in Alzheimer’s Disease

Xiao, M., Xiang, W., Chen, Y., Peng, N., Du, X., Lu, S., Zuo, Y., Li, B., Hu, Y., & Li, X. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.852433 · Cited by 55 · see citing works

Clusterin Associates Specifically with <scp>A</scp>β40 in <scp>A</scp>lzheimer's Disease Brain Tissue

Howlett, D. R., Hortobágyi, T., & Francis, P. T. (2013) · Brain Pathology · doi:10.1111/bpa.12057 · Cited by 51 · see citing works

Combination treatment with leptin and pioglitazone in a mouse model of Alzheimer's disease

Fernández-Martos, C. M., Atkinson, R. A. K., Chuah, M. I., King, A. E., & Vickers, J. C. (2016) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1016/j.trci.2016.11.002 · Cited by 50 · see citing works

Chronic treatment with the α2-adrenoceptor antagonist fluparoxan prevents age-related deficits in spatial working memory in APP×PS1 transgenic mice without altering β-amyloid plaque load or astrocytosis

Scullion, G. A., Kendall, D. A., Marsden, C. A., Sunter, D., & Pardon, M. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.09.002 · Cited by 44 · see citing works

Detection of Aβ plaque-associated astrogliosis in Alzheimer's disease brain by spectroscopic imaging and immunohistochemistry

Palombo, F., Tamagnini, F., Jeynes, J. C. G., Mattana, S., Swift, I. J., Nallala, J., Hancock, J. M., Brown, J. T., Randall, A. D., & Stone, N. (2017) · The Analyst · doi:10.1039/c7an01747b · Cited by 39 · see citing works

Neurofilament light gene deletion exacerbates amyloid, dystrophic neurite, and synaptic pathology in the APP/PS1 transgenic model of Alzheimer's disease

Fernandez-Martos, C. M., King, A. E., Atkinson, R. A. K., Woodhouse, A., & Vickers, J. C. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.07.003 · Cited by 38 · see citing works

Reduced thermal sensitivity and increased opioidergic tone in the TASTPM mouse model of Alzheimer's disease

Aman, Y., Pitcher, T., Simeoli, R., Ballard, C. G., & Malcangio, M. (2016) · Pain · doi:10.1097/j.pain.0000000000000644 · Cited by 33 · see citing works

Alzheimer's disease and synapse Loss: What can we learn from induced pluripotent stem Cells?

Rodríguez-Jiménez, F. J., Ureña‐Peralta, J. R., Jendelová, P., & Erceg, S. (2023) · Journal of Advanced Research · doi:10.1016/j.jare.2023.01.006 · Cited by 33 · see citing works

F-spondin gene transfer improves memory performance and reduces amyloid-β levels in mice

Hafez, D. M., Huang, J., Richardson, J. C., Masliah, E., Peterson, D. A., & Marr, R. A. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.07.038 · Cited by 29 · see citing works

Analysis of serial magnetic resonance images of mouse brains using image registration

Maheswaran, S., Barjat, H., Bate, S. T., Aljabar, P., Hill, D., Tilling, L. C., Upton, N., James, M. F., Hajnal, J. V., & Rueckert, D. (2008) · NeuroImage · doi:10.1016/j.neuroimage.2008.10.016 · Cited by 30 · see citing works

Hyperspectral analysis applied to micro-Brillouin maps of amyloid-beta plaques in Alzheimer's disease brains

Palombo, F., Masia, F., Mattana, S., Tamagnini, F., Borri, P., Langbein, W., & Fioretto, D. (2018) · The Analyst · doi:10.1039/c8an01291a · Cited by 29 · see citing works

Effects of rising amyloidβ levels on hippocampal synaptic transmission, microglial response and cognition in APPSwe/PSEN1M146V transgenic mice

Medawar, E., Benway, T. A., Liu, W., Hanan, T. A., Haslehurst, P., James, O. T., Yap, K., Muessig, L., Moroni, F., Nahaboo Solim, M. A., et al. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2018.12.006 · Cited by 26 · see citing works

The Effects of Physiological and Methodological Determinants on 18 F-FDG Mouse Brain Imaging Exemplified in a Double Transgenic Alzheimer Model

Deleye, S., Waldron, A., Richardson, J. C., Schmidt, M. E., Langlois, X., Stroobants, S. G., & Staelens, S. G. (2016) · Molecular Imaging · doi:10.1177/1536012115624919 · Cited by 26 · see citing works

Characterisation of amyloid-induced inflammatory responses in the rat retina

Howlett, D. R., Bate, S. T., Collier, S., Lawman, A. J., Chapman, T. D., Ashmeade, T. E., Marshall, I. C. B., Anderson, P. J., Philpott, K. L., Richardson, J. C., et al. (2011) · Experimental Brain Research · doi:10.1007/s00221-011-2819-4 · Cited by 22 · see citing works

Effects of Alzheimer's disease transgenes on neurochemical expression in the mouse brain determined by 1H MRS in vitro

Forster, D. M., James, M. F., & Williams, S. R. (2011) · NMR in Biomedicine · doi:10.1002/nbm.1712 · Cited by 22 · see citing works

Autoradiographical imaging of PPARγ agonist effects on PBR/TSPO binding in TASTPM mice

Roberts, J. C., Friel, S. L., Roman, S. A., Perren, M. J., Harper, A. J., Davis, J. B., Richardson, J. C., Virley, D. J., & Medhurst, A. D. (2009) · Experimental Neurology · doi:10.1016/j.expneurol.2009.01.002 · Cited by 21 · see citing works

Longitudinal Characterization of [18F]-FDG and [18F]-AV45 Uptake in the Double Transgenic TASTPM Mouse Model

Waldron, A., Wyffels, L., Verhaeghe, J. A. J., Richardson, J. C., Schmidt, M. E., Stroobants, S. G., Langlois, X., & Staelens, S. G. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160760 · Cited by 20 · see citing works

Impaired chronic pain‐like behaviour and altered opioidergic system in the TASTPM mouse model of Alzheimer's disease

Aman, Y., Pitcher, T., Ballard, C. G., & Malcangio, M. (2018) · European Journal of Pain · doi:10.1002/ejp.1288 · Cited by 20 · see citing works

The occurrence of a deficit in contextual fear extinction in adult amyloid-over-expressing TASTPM mice is independent of the strength of conditioning but can be prevented by mild novel cage stress

Rattray, I., Scullion, G. A., Soulby, A., Kendall, D. A., & Pardon, M. (2009) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.12.037 · Cited by 20 · see citing works

Age-dependent loss of dentate gyrus granule cells in APP/PS1KI mice

Côtel, M.-C., Bayer, T. A., & Wirths, O. (2008) · Brain Research · doi:10.1016/j.brainres.2008.05.052 · Cited by 19 · see citing works

A dual magnetic resonance imaging/fluorescent contrast agent for Cathepsin‐D detection

Ta, R. M., Suchý, M., Tam, J. H. K., Li, A. X., Martínez‐Santiesteban, F., Scholl, T. J., Hudson, R. H. E., Bartha, R., & Pasternak, S. (2012) · Contrast Media & Molecular Imaging · doi:10.1002/cmmi.1502 · Cited by 17 · see citing works

Region-specific neuron and synapse loss in the hippocampus of APPSL/PS1 knock-in mice

Brasnjevic, I., Lardenoije, R., Schmitz, C., van der Kolk, N. M., Dickstein, D. L., Takahashi, H., Hof, P. R., Steinbusch, H. W. M., & Rutten, B. P. F. (2013) · Translational Neuroscience · doi:10.2478/s13380-013-0111-8 · Cited by 16 · see citing works

Continual Trials Spontaneous Recognition Tasks in Mice: Reducing Animal Numbers and Improving Our Understanding of the Mechanisms Underlying Memory

Chan, M., Eacott, M. J., Sanderson, D. J., Wang, J., Sun, M., & Easton, A. (2018) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2018.00214 · Cited by 15 · see citing works

Critical thinking of Alzheimer’s transgenic mouse model: current research and future perspective

Li, X., Quan, M., Wei, Y., Wang, W., Xu, L., Wang, Q., & Jia, J. (2023) · Science China Life Sciences · doi:10.1007/s11427-022-2357-x · Cited by 14 · see citing works

The importance of molecular histology to study glial influence on neurodegenerative disorders. Focus on recent developed single cell laser microdissection

Chadi, G., Maximino, J. R., & de Oliveira, G. P. (2009) · Journal of Molecular Histology · doi:10.1007/s10735-009-9235-0 · Cited by 13 · see citing works

Focal expression of adeno-associated viral-mutant tau induces widespread impairment in an APP mouse model

Dassie, E., Andrews, M. R., Bensadoun, J., Cacquevel, M., Schneider, B. L., Aebischer, P., Wouters, F. S., Richardson, J. C., Hussain, I., Howlett, D. R., et al. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.11.011 · Cited by 12 · see citing works

Near infra-red light treatment of Alzheimer’s disease

Han, M., Wang, Q., Wang, X., Zeng, Y., Huang, Y., Meng, Q., Zhang, J., & Wei, X. (2017) · Journal of Innovative Optical Health Sciences · doi:10.1142/s1793545817500122 · Cited by 12 · see citing works

Abnormalities of Cortical Sources of Resting State Delta Electroencephalographic Rhythms Are Related to Epileptiform Activity in Patients With Amnesic Mild Cognitive Impairment Not Due to Alzheimer's Disease

Babiloni, C., Noce, G., Bonaventura, C. D., Lizio, R., Pascarelli, M. T., Tucci, F., Soricelli, A., Ferri, R., Nobili, F. M., Famà, F., et al. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.514136 · Cited by 12 · see citing works

Are Ischemic Stroke and Alzheimer’s Disease Genetically Consecutive Pathologies?

Filippenkov, I. B., Владимирович, Х. А., Mozgovoy, I. V., Dergunova, L. V., & Limborska, S. A. (2023) · Biomedicines · doi:10.3390/biomedicines11102727 · Cited by 7 · see citing works

Sialic Acid Ameliorates Cognitive Deficits by Reducing Amyloid Deposition, Nerve Fiber Production, and Neuronal Apoptosis in a Mice Model of Alzheimer’s Disease

Xiao, M., Yao, C., Liu, F., Xiang, W., Zuo, Y., Feng, K., Lu, S., Li, X., Li, M., Li, X., et al. (2021) · NeuroSci · doi:10.3390/neurosci3010002 · Cited by 9 · see citing works

Models of Dementia: an introductory overview

Graham, L., & Sutherland, C. D. (2011) · Biochemical Society Transactions · doi:10.1042/bst0390851 · Cited by 4 · see citing works

Chronic BACE-1 Inhibitor Administration in TASTPM Mice (APP KM670/671NL and PSEN1 M146V Mutation): An EEG Study

Lopez, S., Percio, C. D., Forloni, G., Frasca, A., Drinkenburg, W. H. I. M., Lizio, R., Noce, G., Ferri, R., Soricelli, A., Stocchi, F., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21239072 · Cited by 4 · see citing works

Bone-Derived Factors: Regulating Brain and Treating Alzheimer’s Disease

Guan, Q., Cao, Y., Zou, J., & Zhang, L. (2025) · Biology · doi:10.3390/biology14091112 · Cited by 3 · see citing works

Ongoing Electroencephalographic Rhythms Related to Exploratory Movements in Transgenic TASTPM Mice

Percio, C. D., Drinkenburg, W. H. I. M., Lopez, S., Pascarelli, M. T., Lizio, R., Noce, G., Ferri, R., Bastlund, J. F., Laursen, B., Christensen, D. Z., et al. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-190351 · Cited by 3 · see citing works

GAP-43 is associated with faster amyloid-associated neurodegeneration and cognitive decline in Alzheimer’s disease

Li, Y., Xu, X., Tang, L., & Initiative, O. B. O. T. A. D. N. (2025) · Frontiers in Neurology · doi:10.3389/fneur.2025.1629389 · Cited by 1 · see citing works

Neuropathological changes in the TASTPM mouse model of Alzheimer’s disease and their relation to hyperexcitability and cortical spreading depolarization

Gimeno-Ferrer, F., Eitner, A., Noora, N., Bauer, R., Schmidt‐Hieber, C., Schaible, H., & Richter, F. (2024) · Scientific Reports · doi:10.1038/s41598-024-57868-4 · Cited by 1 · see citing works

Characterisation of transgenic mouse models of Alzheimer's disease

Graham, L. (2011) · OpenGrey (Institut de l'Information Scientifique et Technique)

AB deposition and related pathology in an APP x PS1 transgenic mouse model of Alzheimer s disease

Howlett, D. R., Bowler, K., Soden, P. E., D, R., Davis, J. B., Richardson, J. C., Burbidge, S. A., Gonzalez, M. I., A, I. E., Lawman, A., et al. (2008) · Digitum: Institutional Repository of the University of Murcia (University of Murcia)

Transgenic Mouse Models of Alzheimer's Disease

Bornemann, K. D., & Staufenbiel, M. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06653.x · Cited by 89 · see citing works

P1–034: Quantification of cortical neurodegeneration in APP X PS1 transgenic mice

Howlett, D. R. (2006) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2006.05.409

The pathology of APP transgenic mice: a model of Alzheimer's disease or simply overexpression of APP?

Howlett, D. R., & Richardson, J. C. (2009) · PubMed · doi:10.14670/hh-24.83 · Cited by 63 · see citing works

Neurodegenerative Changes Associated with β-Amyloid Deposition in the Brains of Mice Carrying Mutant Amyloid Precursor Protein and Mutant Presenilin-1 Transgenes

Kurt, M. A., Davies, D. C., Kidd, M., Duff, K., Rolph, S. C., JENNINGS, K. H., & Howlett, D. R. (2001) · Experimental Neurology · doi:10.1006/exnr.2001.7717 · Cited by 88 · see citing works